This 4-page issue brief explores pharmacists’ insights into their role in preventing opioid overdose.
Search Results for: (194 results)
Opioid Safety for Hospital Clinicians
Source: UMASS-TOX
This website from the University of Massachusetts’s Division of Medical Toxicology contains several training videos on opioid safety for hospital providers. The 5 instructional videos are intended to educate providers on common pitfalls and evidence-based strategies for safe administration of opioids in the inpatient, hospital setting.
Think it Through: A Guide to Managing the Benefits and Risks of Medicines
Source: U.S. Food and Drug Administration
This patient education brochure addresses how to safely manage the risks of prescription medications. The brochure provides tips for patients on how to reduce the risks of medication through consultation with their prescriber or pharmacist and with simple actions patients can take.
The STOP Measure: Safe & Transparent Opioid Prescribing to Promote Patient Safety & Reduced Risk of Opioid Misuse (2019 Update)
Source: America's Health Insurance Plans
This updated America’s Health Insurance Plans’s (AHIP) report examines how insurers use claims data to measure prescriber adherence to prescribing guidelines – the STOP measure.
Evidence Brief: Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain – Supplementary Materials
Source: Veterans Health Administration, U.S. Department of Veterans Affairs
The supplementary materials to support the systematic review of the evidence for long term outcomes of tapering opioid doses in patients on long term opioid therapy for chronic pain from the Veterans Affairs Evidence Synthesis Program (ESP). These materials include search strategies used in the systematic review, inclusion/exclusion criteria for studies reviewed, evidence tables, and quality assessment of studies included in the review.
Evidence Brief: Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain
Source: Department of Veterans Affairs
A systematic review of the evidence for long term outcomes of tapering opioid doses in patients on long term opioid therapy for chronic pain from the Veterans Affairs Evidence Synthesis Program (ESP). The report analyzes published studies to determine the benefits and harms for patients when tapering their opioid medications to lower doses or discontinuation and reviews whether benefits and harms vary by
DEA Information on Telemedicine (COVID-19)
Source: U.S. Drug Enforcement Agency
This 1 page fact sheet from the Drug Enforcement Administration clarifies that during the Covid-19 public health emergency prescribers will be able to use telemedicine to evaluate a patient and prescribe schedule II-IV drugs.
What Happens When You Flip the Script?
Source: Minnesota Department of Human Services
This 4 minute video from Minnesota’s Flip the Script campaign features interviews with a physician and patient about how the decision to change the patient’s opioid prescription improved the patient’s quality of life and the provider’s relationship to his patients and his practice.
Minnesota Opioid Prescribing Guidelines – 2018 First Edition
Source: Minnesota Department of Human Services
The Minnesota Department of Human Services convened a group of stakeholders to address opioid prescribing in the state through the Opioid Prescribing Improvement Project. The Opioid Prescribing Workgroup produced these 2018 guidelines on opioid prescribing for use by providers
Flip the Script: Discussion Guide for Non-Prescribers
Source: Minnesota Department of Human Services
A 4 page guide for non-prescribers about having difficult conversations with patients about pain management and opioids from Minnesota’s Flip the Script campaign. This guide provides information about the risks of long-term opioid therapy and provides information about understanding acute, post-acute and chronic pain. The guide provides talking points and specific language health care providers can use when talking to their patients and preparing patients to continue the discussion with their prescribing provider.